Justin Irizarry, co-founder and chief financial officer of OrthoNOW, has won the South Florida Business and Wealth Magazine annual Up & Comer Award in the healthcare category. Irizarry, a graduate of Cornell University who then went on to earn an M.B.A. from Wharton, began his career on Wall Street as a vice president at Scott-Macon, Ltd.
Justin Irizarry Wins Up & Comer Award
2 min read Premium comments
In OrthoNOW’s July 10, 2017 news release, the company wrote, “OrthoNOW, the nation’s only orthopedic urgent care franchise, is focused on the assessment and treatment of a range of orthopedic and sports injuries, chronic conditions, and preventative protocols—all on a walk-in basis. OrthoNOW recently announced the development of over 40 units coast to coast so far this year and over 100 by year end. OrthoNOW franchisees are comprised of best in class investors, sophisticated business owners and operators, private equity firms, SCA’s, orthopedic medical groups, and other forward thinkers committed to disrupting traditional healthcare delivery models. The brand’s strategy is focused on wealth building and portfolio diversification. Irizarry recently received South Florida Business Journal’s 40 Under 40 Award for his contributions to the community. He was also selected a finalist for the 2017 CFO Awards by the same publication.”
Irizarry commented to OTW, “I am truly honored and grateful to be honored with this very prestigious award. My journey with OrthoNOW, from its conception to where it is today, has exceed all of my expectations both personally and professionally. When I began my career as a ‘Wall Street’ executive I never dreamed that I would have the opportunity to be the co-founder of a truly revolutionary concept in healthcare. The partnership I have formed with my co-founder, Alejandro Badia, M.D., F.A.C.S., has allowed us to bring our expertise together and conceive a business model that makes both common sense and common cents. The superior outcomes our patients enjoy, and the opportunity to work with all of our amazing OrthoNOW staff, in communities from coast to coast is the reason I get out of bed each and every day.”
“It is very important that the orthopedic community understand that, while time is ticking, OrthoNOW remains a ground level opportunity of merit. Our proven business model allows clinicians to provide superior clinical care while simultaneously creating new revenue streams and future financial security for themselves.” — EH
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.